Table S1. Factors associated with LNM.
Variables | Number | LNM (%) | χ2 value | P value | OR | 95% CI | Cramer’s V (P value) |
---|---|---|---|---|---|---|---|
NMIBC | 11 | 9.10 | 9.547 | 0.002 | 16.03 | 2.00–128.556 | Phi=0.268 (0.001) |
MIBC | 151 | 61.60 | |||||
PT2 | 28 | 46.40 | 12.089 | 0.002 | 0.283 (0.002) | ||
PT3 | 60 | 78.30 | |||||
PT4 | 63 | 52.40 | |||||
PT2 vs. PT3 | 8.958 | 0.003 | 4.17 | 1.59–10.94 | Phi=0.32 (0.003) | ||
PT2 vs. PT4 | 0.275 | 0.6 | Phi=0.055 (0.6) | ||||
PT3 vs. PT4 | 9.103 | 0.003 | 0.3 | 0.14–0.67 | Phi=0.272 (0.004) | ||
Low grade | 10 | 50.00 | 0.04 | 0.84 | 1.41 | 0.39–5.09 | 0.042 (0.596) |
High grade | 152 | 58.60 | |||||
Trigone | 72 | 59.70 | 0.153 | 0.7 | |||
Local recurrence | 56 | 69.60 | 4.743 | 0.03 | 2.13 | 1.07–4.22 | 0.17 (0.03) |
No Local recurrence | 106 | 51.90 | |||||
Lymph node dissection | 123 | 62.60 | 4.394 | 0.04 | 2.17 | 1.04–4.50 | 0.17(0.04) |
No lymph node dissection | 39 | 43.60 |
LNM, lymph node metastasis; OR, odds ratio; NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder.